Physician profile
Eric Lee Peterson
NPI 1497250252
$2,093.03
in general payments reported to CMS, 2019-2025
12 companies · $704 in 2025
The $704 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $196 · 2023: $311 · 2024: $619 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,108.41 | 2021-2025 | Clareon, Luxor, Ngenuity |
| Rxsight INC | $173.20 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Glaukos Corporation | $171.38 | 2023-2025 | Photrexa Cross-Linking Kit, Idosetr |
| Rayner Intraocular Lenses Limited | $159.23 | 2024-2025 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Abbvie INC. | $137.73 | 2023-2025 | |
| Ocular Therapeutix, INC. | $97.57 | 2024-2025 | Dextenza |
| Regeneron Pharmaceuticals, INC. | $95.96 | 2025 | Eylea Hd |
| Harrow Eye, LLC | $59.54 | 2024 | Iheezo |
| Sight Sciences, INC. | $40.13 | 2022 | |
| Amgen INC. | $18.51 | 2024 | Tepezza |
| Depuy Synthes Sales INC. | $16.84 | 2025 | Monovisc |
| Bausch & Lomb Americas INC. | $14.53 | 2023 | Vyzulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.